Lineage Cell Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '25 Dec 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	1,349	403	687	699	1,284	849	Upgrade
Market Cap Growth	117.33%	-41.27%	-1.77%	-45.56%	51.35%	84.30%	Upgrade
Enterprise Value	1,223	289	544	471	1,087	732	Upgrade
Last Close Price	5.32	1.86	3.91	3.92	7.74	5.59	Upgrade
PS Ratio	37.68	11.66	21.32	13.53	95.13	144.57	Upgrade
PB Ratio	19.60	1.44	3.08	2.77	4.54	2.78	Upgrade
P/TBV Ratio	-	5.23	30.84	12.45	11.89	6.86	Upgrade
P/FCF Ratio	-	-	-	307.85	-	-	Upgrade
P/OCF Ratio	-	-	-	187.79	-	-	Upgrade
EV/Sales Ratio	34.92	8.36	16.88	9.11	80.50	124.70	Upgrade
EV/FCF Ratio	-17.69	-	-	207.31	-	-	Upgrade
Debt / Equity Ratio	0.13	0.03	0.05	0.05	0.03	0.04	Upgrade
Debt / FCF Ratio	-	-	-	6.03	-	-	Upgrade
Asset Turnover	0.12	0.09	0.08	0.10	0.03	0.02	Upgrade
Quick Ratio	4.33	3.47	2.02	3.07	2.32	5.35	Upgrade
Current Ratio	4.50	3.65	2.14	3.16	2.37	5.66	Upgrade
Return on Equity (ROE)	-157.75%	-26.73%	-32.07%	-32.37%	-46.52%	-20.05%	Upgrade
Return on Assets (ROA)	-13.65%	-12.53%	-11.80%	-9.44%	-21.77%	-14.16%	Upgrade
Return on Capital (ROIC)	-27.95%	-18.58%	-18.82%	-16.61%	-31.93%	-15.35%	Upgrade
Return on Capital Employed (ROCE)	-25.30%	-21.60%	-25.50%	-21.50%	-38.60%	-26.40%	Upgrade
Earnings Yield	-16.60%	-16.80%	-11.27%	-13.21%	-10.42%	-7.82%	Upgrade
FCF Yield	-5.12%	-21.36%	-15.33%	0.33%	-5.79%	-7.51%	Upgrade
Buyback Yield / Dilution	-25.54%	-15.94%	-1.69%	-3.22%	-9.64%	-3.10%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.